A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

Researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women.

TFPy, developed by researchers at University of Illinois at Urbana-Champaign in US, induces regression of tumours in multiple ...

Patients in the Veritac-2 study were randomized to receive a standard estrogen blocker called fulvestrant, or Arvinas' ...

A Montana fitness-based business owner faces jail time for illegally selling bodybuilding drugs that fight "man boobs." He pleaded guilty to selling ...

As I was taking a psyco-social medical history of a 43-year-old woman, I asked, “What is your problem?” She replied, “I can’t ...

The drug has a half-life of approximately 28 h. Raloxifene is an estrogen agonist in bone, where it exerts an antiresorption effect. The drug does not cause endometrial stimulation and ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

The founder of that clinic, Dr. Milton Edgerton, had cut his teeth caring for transgender people at Johns Hopkins University in the 1960s. There, he was part of a team that established the nation’s ...